PRESS RELEASE: Pharma Regulatory and Pricing Updates; Sign Up for a Complimentary Inside Health Policy Trial
Contact: Steve Reilly
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE -- JULY 18, 2019: Sign up for a free trial subscription to Inside Health Policy, the online news service on health care policy from the regulatory reporting experts at Inside Washington Publishers.
HERE IS A SAMPLE OF THE LATEST INSIDE HEALTH POLICY STORIES THAT YOU CAN READ WITH YOUR FREE TRIAL:
Inside Health Policy delivers reporting you won't find elsewhere -- forward-looking news essential for insurers, health care providers, hospitals and other health policy professionals, including pharmaceutical and medical device manufacturers, lawmakers and other government officials, lawyers, consultants and policy advisers.
You can try Inside Health Policy for the next month with absolutely no obligation. Your trial includes online access to one of our four health newsletters: Inside CMS, FDA Week, Health Exchange Alert or, the newest addition to our lineup, Inside Drug Pricing. Plus, if you choose to subscribe, we'll offer you 50% off for the first year of access.
White House Kills Rebate Rule Because It Would Raise Premiums
President Donald Trump has decided to withdraw a proposed rule to eliminate rebates in Medicare Part D and Medicaid managed care because of concerns the rule would raise premiums for Part D beneficiaries, an administration official told Inside Drug Pricing.
Grassley Says Congress Should Take Up DTC Ad Bill After Court Loss
Senate Finance Committee Chair Chuck Grassley told Inside Drug Pricing he wants Congress to require that drug makers disclose list prices for prescription drugs in television ads, coming a day after a federal court on Monday (July 8) ruled the Trump administration lacks authority under current law to regulate drug makers' television ads.
GOP Slow-Walks Finance Deal Over Inflationary Rebates, CBO Scores
Senate Finance Committee Republicans huddled with HHS Secretary Alex Azar and White House Domestic Policy Council head Joe Grogan Tuesday (July 9) to discuss the panel's emerging drug-pricing package, but the group did not reach an agreement.
Court Sides With Pharma, Tosses Out Trump Admin DTC Ad Rule
A federal court on Monday (July 8) threw out the Trump administration's rule requiring drug makers to disclose list prices in television advertisements because the judge found regulating television ads for prescription drugs is outside CMS' authority.
Trump Plans Order Giving U.S. Most Favored Nation Status For Drugs
President Donald Trump is writing an executive order to ensure the United States pays no more than any other country for prescription drugs, he said July 5.
You can try Inside Health Policy for the next month with absolutely no obligation. Your trial includes online access to the newsletter you choose: Inside CMS, FDA Week, Health Exchange Alert, or Inside Drug Pricing - and please call us if you want access to a second newsletter. Plus, if you choose to subscribe, we'll offer you 50% off for the first year of access.
For more information about the 50% off, first-year savings, contact Steve Reilly at 703-562-8992, or e-mail him at email@example.com.